Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New head lice lotion could beat old shampoo in Head-to-Head trial

NCT ID NCT07191457

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compares a new head lice lotion (Elimax Green Lotion with Emogreen) to a standard lice-killing shampoo (Walgreens Lice Killing Shampoo). About 86 people aged 6 months and older with active head lice will use one of the two treatments. Researchers will check how well each treatment clears lice and nits after 10 days, and monitor for any skin or eye irritation. The goal is to see if the new lotion works as well or better than the shampoo.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Elimax Green Lotion with Emogreen (a physically acting lotion) and Walgreens Lice Killing Shampoo (containing piperonyl butoxide and pyrethrum extract)
What this could lead to
If successful, this could offer a new, effective head lice treatment that may be gentler on the scalp and less likely to cause resistance.
What could go wrong
This is a small, early-stage trial with only 86 participants. The new lotion may not work better than the existing shampoo, and results may not apply to everyone. Skin or eye irritation is possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 86 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 months and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Gender: male / female. * Female subjects with childbearing potential who test negative for pregnancy and agree to use a reliable method of birth control (as described in section7.8) or remain * Age ≥ 6 months of age at the time of enrollment. * Subject must have an active head lice infestation defined as at least 5 live lice (adults and/or nymphs) and 5 live nits based on magnified observations, present on the scalp and/or hair, as determined by a trained evaluator. * Subject is in good general health based on medical history. * Following application per designated product timeline shampoo hair using Johnson's baby shampoo (See figure 4 for shampoo image) to rinse out the product according to the study product its IFU. Subject agrees not to additionally shampoo, wash, or rinse their hair or scalp for 24-hours post treatment. * The subject agrees not to cut or chemically treat their hair while participating in the study. * Subject agrees to follow all study instructions, including attending all follow-up appointments. * Agree to not use any other anti-lice treatment or medicated hair grooming products for the duration of the study (through Day 10 visit). * The parent or legal guardian of a child must be willing to have other family members screened for head lice. If other household members are found to have head lice and are eligible, they must be either enrolled in the study OR receive the standard of care at the site and in the same manner as study participants. * Have a single place of residence or agree to remain at the current residence for the duration of the study. * The subject or his/her parent/legal guardian (from age 12-17), must give written informed consent, after having been informed orally and by written text about the benefits and potential risks of the trial, as well as information regarding the insurance, taken out to cover the subjects participating in the study. A caregiver must sign an informed consent agreement for children not old enough to do so. Children aged 6-11 years of age will be administered a child's assent form. Subject or his/her parent/legal guardian must be capable of understanding and providing written informed consent. Exclusion Criteria: * Application of any form of head lice treatment, whether prescription or over-thecounter (OTC), or home remedy for 14 days prior to their screening visit (Visit * Application of any topical medication of any kind on the hair or scalp for a period of 48 hours prior to the screening visit. * Use of systemic or topical drugs or medications, including systemic antibiotics, which in the opinion of the investigative personnel may interfere with the study results. * Known skin allergies, multiple drug allergies or multiple allergies to cosmetic products. * History of allergy or hypersensitivity to active ingredients, or constituents of the test products. * Subject with any visible skin/scalp condition at the treatment site which, in the opinion of the investigative personnel, will interfere with the evaluation of the test product. * Subjects with chronic scalp disorder. * Subject or his/her legal guardian who, in the opinion of the investigative personnel, do not understand the subject requirements for study participations and/or may be likely to exhibit poor compliance with the required visits. * Females who are pregnant or nursing. * Hair longer than waist length. * Subject suspected or known not to follow instructions * Previous participation in this study or participation in any other investigational trial within the preceding 14 days. * The subject is directly affiliated to the investigator site personnel and/or their immediate families. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted. * The subject is an Oystershell employee or is an employee of a third-party organizations involved in the study. * Exclude families with 4 or more household members. * People with dreadlocks or clip in hair that cannot be removed or a person who does not want to remove these. * Hair that is too difficult to work with, assessed by the study staff. * Families excluded where lice exist however family member declines enrollment in the study. * Subjects who are receiving, or are expected to receive, any antibiotic therapy during the study period will be excluded. * No more than one working subject per household may be excluded from evaluation if he is assessed as being lice by himself or caregiver. Only working male can be excluded from evaluation if individual is bald or hair no longer than half inch and deemed lice free by himself or another adult. * All household members of the subject, other than excluded male adult, must be screened for head lice by a licenced head lice professional. If additional household members are found to have head lice and meet the study criteria, they will be referred to LSRN Research and enrolled in study. If a household member declines enrollment, all family members will be excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Head lice are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • LSRN Research

    RECRUITING

    Enid, Oklahoma, 73701, United States